Loading

Our Programs
About Us
News
Patient Portal

Request a Consultation

Home
News
The new fluoride? FDA greenlights rapamycin oral health trial [Longevity.Technology]

In the News|December 8, 2023

The new fluoride? FDA greenlights rapamycin oral health trial [Longevity.Technology]

A dentist examining an older man's teeth during a check-up

Longevity.Technology wrote about Optispan’s collaboration with the RAPID trial to assess the efficacy of rapamycin in treating periodontal disease.

Published by Teddy Otero

More from Optispan

August 21, 2026
Dr. Nicki Byrne with the Puget Sound Business Journal
August 10, 2026
Two Sheet Pan Salmon Dinners from Dr. Nicki Byrne
August 4, 2026
The FDA Did Not Approve Peptides. Here Is What Actually Happened.

Looking for a Healthspan Cheat Sheet?

Before any supplement or gadget, get the free Optispan guide. Our Pillars, the principles, the targets, and the science, all in one place.

Do not fill this in

I confirm that I am 18 years of age or older.(required)

Email address

We will email you the guide and nothing else. This does not sign you up for our newsletter. See our Privacy Policy.

Physician led longevity and performance.
Based in Seattle.

Programs

Optispan Helix Core
Optispan Helix
What Your Plan Includes
Request a Consultation

Explore

About Us
News
Careers
Contact Us
Patient Portal

Connect

LinkedIn
Instagram
X/Twitter

© 2026 Optispan, Inc. All rights reserved.

Privacy & Security Policy
Terms of Use
Cookie Consent